2HQ0.XETRA Tilray Brands, Inc.

Healthcare Drug Manufacturers - Specialty & Generic XETRA Stock Exchange
2.48 EUR
Close of Nov 6, 2026
2.21 11.60
Market cap
EUR 367M
P/E
-
P/B
0.27x
ROE
-10.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.

Is 2HQ0.XETRA undervalued?

Graham number

The Graham number of Tilray Brands, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tilray Brands, Inc. fundamental analysis

No fundamental analysis for Tilray Brands, Inc. yet.

Tilray Brands, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and se…

Full company profile